Ubinexus focuses on the overall design capabilities of satellite communication payloads and satellite-based comprehensive digital processing technology to meet the multi-dimensional needs of low-orbit mega-constellation construction and provide users with the world's leading communication payload system.
Insyce
Series C in 2025
Insyce creates equipment and apparatus for science. Its business strives to provide tools and technology for bio labs that monitor the environment to deliver accurate data and speedy chemical analysis while keeping lab costs down for their clients. It is dedicated to providing upper biological separation equipment and chemical analysis tools for global clients, cutting down on client operating expenses, and adding value for clients.
Uni-Sentry
Series A in 2025
Uni-Sentry offers information security testing tool chain and information security compliance testing platform for intelligent networked vehicles, vehicle information security penetration testing services, autonomous driving GNSS anti-spoofing anomaly detection solutions, National secret algorithm vehicle hardware security module HSM solution.
Tota Info
Series A in 2024
Tota Info is a technology company focused on delivering integrated hardware and software solutions for smart factories within the semiconductor industry. The company specializes in intelligent manufacturing, utilizing advanced technologies such as Auto Guided Vehicle (AGV) drones, artificial intelligence, and deep learning. Tota Info's offerings cater to domestic semiconductor manufacturers and encompass the entire industrial chain, including silicon wafer production, packaging, and testing. By implementing Tota Info's solutions, industrial users can enhance quality control, improve machine efficiency, streamline product manufacturing processes, and manage costs effectively.
Northern Hemisphere Technology
Venture Round in 2024
Northern Hemisphere Technology is a high-tech company specializing in automotive-grade one-piece molded inductors. Northern Hemisphere focuses on high-performance and high-quality products, uses technology to serve customers and the market.
Shandong Bona Group
Series A in 2024
Shandong Bona Group is a biotechnology company that specializes in the development of material separation, extraction and purification.
Runfu Power
Venture Round in 2024
Runfu Power is a planetary roller screw R&D manufacturer, committed to the development and production of planetary roller screws.
Keylights
Series B in 2024
Keylights specializes in the research, development, production, and sales of in vitro diagnostic instruments. The company offers high-performance, cost-effective solutions for medical sample analysis, utilizing advanced technologies such as chemiluminescence and immunofluorescence. Keylights aims to provide both domestic and international markets with ultra-stable products and contract development and manufacturing organization (CDMO) services. By focusing on innovative diagnostic instruments, Keylights enhances the ability of users to gain detailed insights from their samples.
ThunderBio
Series B in 2024
ThunderBio Innovation Limited, established in 2018 and based in Jiaxing, China, specializes in the manufacture and marketing of medical equipment focused on molecular biology. The company leverages advanced microfluidics technology to develop a range of products, including microfluidic chips, instruments, and reagents. As a full-service provider, ThunderBio integrates research and development with manufacturing, offering innovative scientific instruments such as the Comet High Throughput Sorting System, Galaxy Single Cell Analysis System, and Xingyun Digital PCR System. These products support applications in antibody screening, synthetic biology, cancer research, and high-throughput drug screening. Additionally, the digital PCR diagnostic system provided by ThunderBio enables the digitization of medical test results, offering valuable insights for medication guidance and predictive treatment, thereby enhancing reliability for medical practitioners and researchers.
ACXEL
Series A in 2024
ACXEL Tech specializes in large area electronics, focusing on digital microfluidic cell manipulation platforms that enhance drug discovery and biological research. By transforming active pixels into precise engines, ACXEL's technology enables the rapid transport of liquid droplets, facilitating complex experimental procedures at the single-cell level. This innovative approach supports various applications, including cell line development, cell therapy, synthetic biology, and antibody therapy. The platform's high throughput and low-cost design provide clients with the ability to increase productivity and efficiency in their research efforts across chemistry, biology, and medical technology.
CVA Chip
Series B in 2023
CVA Chip is a developer and manufacturer of intelligent sensing chips tailored for applications in the automotive sector, Internet of Things (IoT), and mobile devices. The company focuses on research and development of high-performance processors and chips that facilitate advanced computing hardware, thereby enabling edge intelligence. Its multi-modal Sparrow architecture platform supports various projects, including 3D face recognition vision chips, binocular vision chips, intelligent decoding scaler chips, and a series of MCU+ perception and driver chips. Through its innovative technology, CVA Chip aims to enhance the capabilities of intelligent devices across multiple industries.
Best Ray
Seed Round in 2023
Bolui Laser is a high tech enterprises that focuses on independent research and development and industrialization of high-end lasers and laser applications. It offers clients h innovative solutions in the fields of industrial processing, cutting-edge scientific research, environmental monitoring, semiconductors, radar remote sensing, etc. and competitive products and advanced laser technology solutions to continue to create value for customers.
Tage Zhixing
Series C in 2023
Beijing Tage Zhixing Technology Co., Ltd. is a high-tech enterprise focusing on mining vehicle unmanned driving technology research, product development, and overall engineering solution design and implementation of unmanned mines. Tage Zhixing has launched a car-ground-cloud collaborative smart mine unmanned transportation system, which realizes cloud intelligent dispatching management, 4G.
Shenzhen CardioACC
Seed Round in 2023
Shenzhen CardioACC Ltd specializes in advanced cardiovascular interventional, natural cavity imaging and advanced diagnostic procedures.
Wuken New Materials
Venture Round in 2023
Wuken New Materials specializes in the development and manufacture of extreme-temperature thermal field compounds.
Anhui YOFC Advanced Semiconductor
Series A in 2023
Anhui YOFC Advanced Semiconductor focuses on the R&D and manufacturing of silicon carbide (SiC) power semiconductor products. They provide high-quality services and can currently supply 650V to 3300V SiC SBD and SiC MOSFET-related products.
Jitong Life
Seed Round in 2023
Jitong Life is a biotechnology company that focuses on the research and development, production and sales of high-end life science instruments.
Jingcai Intelligent
Seed Round in 2023
Jingcai Intelligent is an AI company that focuses on the continuous management of musculoskeletal pain and sports health. Jingcai Intelligent provides digital screening and functional evaluation, health An overall solution for management and scientific training.
Saint Chemicals Materials
Seed Round in 2023
Saint Chemicals Materials is an environmental technology company that focuses on the development and production of microcrystalline material adsorbents. The company aims to serve the materials industry by conducting research and development on materials characterized by selective adsorption, recyclability, high-temperature resistance, and low operating costs. Through its innovations, Saint Chemicals Materials provides clients with high-quality products that meet industry standards.
Meidong Huicheng
Venture Round in 2023
Meidong Huicheng is a high-tech company focused on developing a big-data platform for lab automation supplies and tools. The business has put together a qualified research, development, and design team. Their quality system may adapt to their needs for change by providing detailed documentation of their stringent chain manufacturing and quality control processes.
Insyce
Series B in 2023
Insyce creates equipment and apparatus for science. Its business strives to provide tools and technology for bio labs that monitor the environment to deliver accurate data and speedy chemical analysis while keeping lab costs down for their clients. It is dedicated to providing upper biological separation equipment and chemical analysis tools for global clients, cutting down on client operating expenses, and adding value for clients.
HemaCell
Series A in 2022
Xueji Bio is a new cell therapy company founded by returnee experts to regenerate hematopoietic lineages (including blood cells and immune cells) in vitro, with unique stem cell reprogramming, editing and differentiation technologies. The company's unique iPSC establishment technology and gene targeting technology can quickly establish a platform using platelet cells as a drug delivery carrier.
Vinchin
Series A in 2022
Founded in 2015, Vinchin is a software company dedicated to developing data protection solutions specifically for virtual machine environments. The company specializes in backup, instant recovery, and disaster recovery services across various hypervisors, including VMware, XenServer, RHV/Ovirt, OpenStack, and Sangfor HCI. Vinchin concentrates exclusively on virtual machine data protection, distinguishing itself from other backup vendors. Its solutions are designed to safeguard operating systems, data, and applications against threats such as human error, viruses, hardware failures, and other disasters. With a mission to be a leading provider of VM backup solutions, Vinchin's offerings are accessible to clients globally, emphasizing ease of use and reliability.
Sibionics
Series C in 2022
SiBionics is a medtech company based in Shenzhen, China, focused on the research and development of active implantable medical devices and medical artificial intelligence. The company specializes in creating innovative solutions for various health conditions, including retinitis pigmentosa, diabetes, cardiovascular diseases, and gastrointestinal tumors. SiBionics develops artificial intelligence technologies for medical imaging and implantable devices, including retinal electrical stimulators and continuous glucose monitors. Their work also encompasses health management, disease screening, and diagnostics, using approaches such as visual coding, medical imaging AI, and big data analytics to enhance patient care and address chronic diseases. Through these advancements, SiBionics aims to provide cost-effective products that improve long-term monitoring and treatment options in the medical field.
ABclonal
Series D in 2021
ABclonal Inc. is a life science research and diagnostic reagents provider based in Woburn, Massachusetts, established in 2016. The company specializes in offering a range of biological research agents and services, including next generation sequencing library preparation kits, molecular biology products, catalog antibodies, catalog proteins, ELISA kits, and tools for western blotting. Additionally, ABclonal provides peptide, antibody, and protein services. The company distributes its products through a network that spans Europe, Asia, North America, and Oceania. With a team of scientists from leading universities, ABclonal is committed to enhancing the quality of life science research through its high-quality offerings.
Engipower
Series A in 2021
Engipower is a smart energy systems company that focuses on optimizing the operation and management of energy systems, particularly in urban settings. It specializes in monitoring the operational status of smart city heating systems, diagnosing faults, and providing decision support for dispatch. Engipower aims to enhance the efficiency of urban central heating and industrial steam supply, catering to the growing demand for integrated energy services. The company offers digital intelligent operation management solutions that facilitate sophisticated control over energy systems, thereby improving overall energy management for users.
WeMed Medical
Series D in 2021
WeMed is a developer of digital angiography machines designed for use in the clinical fields of radiology and cardiology. The company focuses on enhancing department operations and providing training for medical professionals. Additionally, WeMed implements an international strategy for product research and development, ensuring that its offerings are continuously optimized and upgraded to meet the evolving needs of healthcare providers.
ABclonal
Series C in 2021
ABclonal Inc. is a life science research and diagnostic reagents provider based in Woburn, Massachusetts, established in 2016. The company specializes in offering a range of biological research agents and services, including next generation sequencing library preparation kits, molecular biology products, catalog antibodies, catalog proteins, ELISA kits, and tools for western blotting. Additionally, ABclonal provides peptide, antibody, and protein services. The company distributes its products through a network that spans Europe, Asia, North America, and Oceania. With a team of scientists from leading universities, ABclonal is committed to enhancing the quality of life science research through its high-quality offerings.
3D Medicines
Venture Round in 2020
3D Medicines is a biopharmaceutical company focused on the research, development, and commercialization of personalized treatments for cancer. By utilizing individuals' genetic information, the company aims to enhance the prevention, diagnosis, and management of cancer as a chronic disease. 3D Medicines specializes in creating differentiated immuno-oncology drugs designed to improve patient outcomes, extending both survival time and quality of life for those affected by cancer. The company generates its revenue exclusively from the Chinese market.
APTBIO
Series A in 2020
APTBIO was initiated by Shanghai Institutes for Biological Sciences under Chinese Academy of Sciences in 2004, and is mainly engaged in the application of mass spectrometry technology. The so-called mass spectrometry technology is to measure the quality of protein molecules to carry out the identification of protein molecules, the modification of protein molecules and the study of protein molecule interactions.
Targene Medical
Series A in 2020
Targene Medical concentrates on the study, creation, and distribution of tools for accurate and early cancer diagnosis. It is dedicated to entire cancer diagnostic and treatment process. It provides research and development of early detection tools for one type of cancer, multiple types of cancer, and even all cancers.
Sidi Diagnostics
Venture Round in 2020
Sidi Diagnostics is a medical technology company that focuses on new molecular diagnostic technologies.
3D Medicines
Venture Round in 2020
3D Medicines is a biopharmaceutical company focused on the research, development, and commercialization of personalized treatments for cancer. By utilizing individuals' genetic information, the company aims to enhance the prevention, diagnosis, and management of cancer as a chronic disease. 3D Medicines specializes in creating differentiated immuno-oncology drugs designed to improve patient outcomes, extending both survival time and quality of life for those affected by cancer. The company generates its revenue exclusively from the Chinese market.
RemeGen
Private Equity Round in 2019
RemeGen, Ltd. is a biopharmaceutical company based in Yantai, Shandong Province, China, specializing in the research, development, manufacture, and commercialization of novel biologics, particularly monoclonal antibodies and antibody-drug conjugates. The company focuses on addressing unmet medical needs for patients with life-threatening conditions, offering products such as Telitacicept for systemic lupus erythematosus and Disitamab Vedotin for various cancers. RemeGen's innovative therapies target major diseases, including autoimmune disorders, oncology, and ophthalmology. With additional laboratories and offices in Beijing and California, RemeGen primarily operates in China while also maintaining a presence in the United States, where it derives a significant portion of its revenue.
WeMed Medical
Series C in 2019
WeMed is a developer of digital angiography machines designed for use in the clinical fields of radiology and cardiology. The company focuses on enhancing department operations and providing training for medical professionals. Additionally, WeMed implements an international strategy for product research and development, ensuring that its offerings are continuously optimized and upgraded to meet the evolving needs of healthcare providers.
Ruiyi Biotechnology (Realbio Technology)
Series A in 2019
anghai Ruiyi Biotechnology Co., Ltd. was established in Shanghai in 2014 and is a national high-tech enterprise. At present, it has established branches in Hangzhou, Qingdao and Guiyang. It is a professional genetic technology and health service company. The company has always been adhering to the corporate philosophy of "forge ahead" and is committed to providing customers with the highest quality products and services. Since its inception, Shanghai Ruiyi Biotechnology Co., Ltd. has quickly established cooperation with many well-known research institutes at home and abroad, and has attracted many elites from the fields of genomics, medicine and bioinformatics. Up to now, the company has obtained more than 40 software copyrights and a number of patents.
LandSpace
Series B in 2019
LandSpace is a Chinese company engaged in the development and operation of rockets. Focusing on the small and medium-sized commercial aerospace application market, the company is committed to the development of liquid fuel rocket engines and commercial launch vehicles with independent intellectual property rights. It designs, manufactures, and tests products with highly integrated design capabilities and stand-alone innovation capabilities. The company is a member of the International Astronautical Federation (IAF) and a national high-tech enterprise. It is based in Beijing, China
Airwing.ai
Series A in 2018
Beijing Airwing Aviation Technology Co., Ltd. specializes in the research, design, and manufacture of unmanned aerial vehicles (UAVs) tailored for the electric power industry. Founded in 2009 and based in Beijing, the company provides various services, including data collection, flying tours, and defect analysis of transmission lines. Airwing.ai's UAVs are employed for industrial data collection and inspection of power lines, wind stations, photovoltaic stations, coal-fired thermal power plants, and atmospheric monitoring. The company has developed a closed-loop system for comprehensive data collection and analysis, integrating drone autonomous operations with artificial intelligence technology. Its technical architecture encompasses perception, platform, and application layers, enhancing the efficiency and effectiveness of its UAV solutions.
XGimi
Corporate Round in 2018
XGimi is a Chinese company based in Chengdu that specializes in the design and manufacture of multi-functional projectors and laser TVs. Founded in 2012, XGimi focuses on creating high-performance, high-definition projectors that incorporate an Android operating system and offer three-dimensional viewing capabilities. The company aims to provide affordable giant-screen projection solutions to consumers worldwide, emphasizing innovation and quality in its product offerings.
CloverSec Labs
Series A in 2017
CloverSec Labs experimental research is mainly responsible for security vulnerabilities, the latest security information tracking, security event analysis Trojan virus, well-known platform vulnerabilities submitted with the application submitted to the relevant vulnerability CVE vulnerabilities and qualifications, submit loopholes in the SRC platform.
Zhimai Yinqing
Seed Round in 2017
Zhimai Yinqing provides clerk task execution, adjust task, and member assignment services. They also provide regional management, statistics, view task performance, and custom marketing task services.
BayNexus
Series B in 2016
BayNexus develops mobile terminal devices for medical use. The company specialises in developing wireless medical mobile terminals designed to help medical personnel track patient conditions, manage medical records, and diagnose pathological specimens, providing innovative technological support to improve efficiency.
Dayang Parking
Series B in 2014
Dayang Parking Co., Ltd. specializes in the design, manufacture, installation, and maintenance of mechanical parking equipment in China. Founded in 2001 and headquartered in Weifang, the company offers a diverse range of products, including puzzle parking systems, vertical and horizontal parking systems, car elevators, and various types of parking lifts. Dayang Parking addresses the challenges of urban parking by providing automated solutions that optimize space efficiency. In addition to its domestic operations, the company exports its products to markets in Europe, Southeast Asia, and the United States, thereby extending its reach in the global parking equipment sector.
KungFu Animation
Angel Round in 2014
KungFu Animation is a prominent developer of high-quality 3D animations, producing over ten notable projects annually that are often broadcast on national platforms like CCTV and gain significant viewership. The company collaborates with a global network of creative teams and boasts extensive distribution capabilities, reaching over 1,000 domestic media outlets and operating hundreds of independent television stations across China. Additionally, KungFu Animation has established distribution networks in more than 100 countries, enabling its content to reach a worldwide audience. The firm specializes in creating Chinese animation intellectual property derivatives, with popular titles including "Little Play Skin," "Cassirron," and "X Dream Story."
Huashi Jingcheng
Angel Round in 2013
Huashi Jingcheng is an education cloud platform. It also engages in research and development, production, and sales of educational information products, solutions, and digital teaching resource software. They provide solutions for advocates, pioneers, leaders, and practitioners.
Hoteam Software
Angel Round in 2010
Hoteam Software is a provider of intelligent manufacturing solutions aimed at transforming enterprise operations. The company emphasizes independent innovation and the development of controllable industrial software to support the advancement of China's industrial sector. Hoteam Software specializes in 3D software and offers a comprehensive range of services, including computer-aided design (CAD), computer-aided manufacturing (CAM), computer-aided process planning (CAPP), product data management (PDM), product lifecycle management (PLM), manufacturing execution systems (MES), warehouse management systems (WMS), and supplier relationship management (SRM). By leveraging its technology platforms, Hoteam Software enables industrial enterprises to enhance work efficiency and reduce operational costs through three-dimensional design, intelligent management, and visualization capabilities.
Weishi Energy
Weishi Energy is a hydrogen fuel cell product research and development manufacturer, focusing on the market operation of hydrogen fuel cell technology, and is committed to promoting the low-carbon sustainable development of human energy. It is mainly engaged in the research and development, production and sales of hydrogen fuel cell products. At present, Weishi Energy has deployed five R&D centers in Shanghai, Baoding, Japan, Germany, and Canada. It has established a culturally diverse and technologically advanced R&D team, and strictly follows the V model development process to create vehicle-level fuel cell power systems and components. The company's main products include fuel cell engines, electric stacks, 35MPa/70MPa on-board hydrogen systems, bottle valves and pressure reducing valves, etc.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.